SF68 SLIPIDO
)
PROBIOTICS for DYSLIPIDEMIA AND CHOLESTEROL On basis of its proprietary probiotic strain SF68 and its unique characteristics, Cerbios Pharma developed a finished product, for the management of dyslipidemias, cholesterol and metabolic syndrome.
The formulation contains also phytosterols (well known for their efficacy on reduce cholesterol) and folic acid (as 5-MTHF, the active form), that reduces high level of homocystein. Precinical evidences confirm efficacy of the product and we are now running a clinical trial on humans, to confirm existing results. Cerbios is searching for commercial Partners, also in private label.